secwatch.observer — SEC 8-K summary
======================================

Issuer:     INTELLIGENT BIO SOLUTIONS INC. (INBS)
CIK:        0001725430
Form:       8-K
Filed at:   2025-10-21T23:59:59+00:00
Accession:  0001493152-25-018806
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Intelligent Bio Solutions stockholders approve reverse stock split, warrant share issuance, and incentive plan expansion
--------------------------------------------------------------------------------

- Elected four directors: Boyages, Hurd, Isenberg, Fraser. Boyages received 1,349,921 for, 503,182 withheld.
- Approved amendment to 2019 Long Term Incentive Plan, increasing authorized shares from 1.3M to 1.795M (495,000 new shares).
- Approved issuance of up to 4,147,616 shares upon warrant exercise (over 20% of outstanding common stock).
- Approved reverse stock split at ratio of 1-for-2 to 1-for-10 within 12 months, at Board's discretion, to regain Nasdaq bid price compliance.
- Ratified UHY LLP as independent auditor for fiscal year ending June 30, 2026 (4,246,183 for, 227,964 against).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1725430/000149315225018806/0001493152-25-018806-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1725430/000149315225018806/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-018806

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer